Benlysta 120 mg and 400 mg powder for concentrate for solution for infusion *
Company:GlaxoSmithKline (Ireland) Ltd
Legal Category:Product subject to medical prescription which may not be renewed (A)
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company